the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Only 70-80% mental patients fully recover due to faith in traditional treatment

KOTA BHARU: Failure to seek early treatment due to having more faith in traditional treatment has resulted in only 70 to 80 per cent of mental patients recovering after being treated in hospital.

Raja Perempuan Zainab II Hospital (HRPZ II) Department of Psychiatry head Dr Fariza Yahya said most mental patients only sought treatment at the hospital after more than two years of experiencing the problem.

“Many of the patients we saw said that their families took them to seek treatment with bomoh (shaman) first. But, when they see the patient’s condition worsening, they will then come to the hospital.

“The delay in getting early treatment has resulted in many patients not recovering 100 per cent due to their (patients’) deteriorating mental capacity,” she told reporters after the launch of the Community Mental Health Centre (MENTARI) project at the Ketereh Health Clinic, here, today.

Also present were Kelantan Social Security Organisation (Socso) director Nora Yaacob and Socso Return to Work division head Rosmawati Mat.

Dr Fariza said that early treatment is crucial to ensuring patients recover and can go about their normal routine, including being able to work, but they must take their medicine as prescribed by doctors.

According to her, for the MENTARI programme, patients undergoing rehabilitation will be given skills in their fields of interest, such as doing business, making ice cream and burgers as well as working with employers.

At the same time, over 2,000 new cases annually involving mental patients, including in terms of behaviour, are recorded seeking treatment at the HRPZ II Department of Psychiatry.

“Within a month, we received 200 to 300 new cases, including teenagers and the youngest is 13 years old. Many children from divorced parents are also found to have mental problems,” she said. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings